Tenofovir Completed Phase 2 Trials for HIV Seropositivity Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01174914Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+